Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

NCT01905046 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Atypical Ductal Breast Hyperplasia
BRCA1 Mutation Carrier
BRCA2 Mutation Carrier
Ductal Breast Carcinoma in Situ
Lobular Breast Carcinoma in Situ

Interventions

DRUG: metformin hydrochloride
OTHER: placebo

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]